Transplant
Conference Coverage
Maribavir seen as superior to other antivirals for CMV clearance post transplant
Conference Coverage
Using engineered T cells reduced acute, chronic GVHD
Conference Coverage
Transplant-related mortality higher with CD34 selection
Conference Coverage
Steroid complications in GVHD common, boost costs of care
Conference Coverage
Chronic GVHD therapies offer hope for treating refractory disease
Guidelines
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
From the Journals
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant
But only if caregivers are equipped for outpatient care.
From the Journals
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
‘Practice changing’: Ruxolitinib as second-line in chronic GVHD
Conference Coverage
Allogeneic transplant leads to durable remissions in T-cell lymphomas
Retrospective study demonstrates overall survival over 50% at 5 years, though transplant-related mortality and graft-versus-host disease need to...
Feature
Can receiving HSCT care at home reduce the risk of GVHD and COVID-19?
Researchers are studying whether receiving posttransplant care at home can improve outcomes.